Home Wires

Executive Series - Bionomics Ltd (BNO) CEO & MD, Dr Deborah Rathjen

CommSec

Online Stockbroker

CommSec’s Tom Piotrowski speaks with Bionomics Ltd (BNO) CEO & MD, Dr Deborah Rathjen about the company’s newly signed deals with Merck, its new anxiety drug trial and its cancer treatment trials To view more Executive Series interviews, visit: (VIEW LINK)

CommSec
CommSec
Online Stockbroker
Online Stockbroker

CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

most popular

Equities

Buy Hold Sell: The top small-cap picks for 2023 (and 2 fundie favourites)

Livewire Markets

Funds

A portfolio of under-appreciated, mispriced and winning stocks

Munro Partners

Equities

6 stocks for a full portfolio reset in 2023

Livewire Markets

Equities

What worked in equity markets in 2022

Aoris Investment Management

view all